Zeng Tian-shu, Chen Lu-lu, Xia Wen-fang, Li Hui-qing, Zhou Min
Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005 Feb;25(2):143-6.
To observe the effect of Chinese herbs for supplementing Shen and strengthening bone (HB) on myelogenic osteoclasts formation, and gene expression of interleukin-6 (IL-6), IL-6 receptor (IL-6R) and gp130 in bone marrow.
Seventy-two healthy female SD rats of 3 months, were randomly divided into three groups, 24 in the sham-operated group (A), 24 in the ovariectomized group (B) and 24 in the after ovariectomy HB treated group (C). Bone marrow cells of 6 rats from each group were respectively collected and cultured at four time points (2nd, 4th, 6th and 12th weeks after operation). After 6 days of culture, the bone marrow cells were differentiated by Wright-Giemsa stain and TRAP stain, and total RNA in them was extracted by TRIZOL.
Beginning from the 2nd week, the osteoclasts formation in Group B was higher than that in Group A (P < 0.05), and IL-6, IL-6R gene expression significantly increased in Group B (P < 0.05 or P < 0.01). These changes reached the peak in the 4th to 6th week, with the level maintained to the 12th week. As for comparison of Group B and C, the above-mentioned changes were significantly weakened in the latter (P < 0.05 or P < 0.01). No significant change of gp130 gene expression revealed in the whole course in either group.
HB could inhibit the myelogenic osteoclasts formation in ovariectomized rats, this effect may be correlated with, partially at least, its inhibitory effect on the over-expressed IL-6 and IL-6R gene expression in myelocytes after ovariectomy.
观察补肾壮骨中药对骨髓源性破骨细胞形成及骨髓中白细胞介素-6(IL-6)、IL-6受体(IL-6R)和gp130基因表达的影响。
将72只3月龄健康雌性SD大鼠随机分为三组,假手术组(A组)24只,去卵巢组(B组)24只,去卵巢后补肾壮骨治疗组(C组)24只。分别于术后2、4、6、12周四个时间点采集每组6只大鼠的骨髓细胞进行培养。培养6天后,对骨髓细胞进行瑞氏-吉姆萨染色和抗酒石酸酸性磷酸酶(TRAP)染色鉴定分化情况,并用TRIZOL法提取细胞总RNA。
术后第2周起,B组破骨细胞形成高于A组(P<0.05),B组IL-6、IL-6R基因表达显著增加(P<0.05或P<0.01)。这些变化在第4至6周达高峰,并维持至第12周。B组与C组比较,上述变化在C组明显减弱(P<0.05或P<0.01)。两组全程gp130基因表达均无明显变化。
补肾壮骨中药可抑制去卵巢大鼠骨髓源性破骨细胞形成,此作用可能至少部分与其抑制去卵巢后骨髓细胞中IL-6和IL-6R基因的过度表达有关。